Detailed analysis of 'work as imagined' in the use of intravenous insulin infusions in a hospital: a hierarchical task analysis. Issue 3 (23rd March 2021)

• Record Type: Journal Article
• Authors: Iflaifel, Mais Hasan; Lim, Rosemary; Crowley, Clare; Ryan, Kath; Greco, Francesca
• Is Part Of: BMJ open. Volume 11:Issue 3(2021)
• Publication Date: 2021-03-23
• Subjects: diabetes & endocrinology -- quality in health care -- protocols & guidelines -- qualitative research; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2020-041848
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objective: Variable rate intravenous insulin infusions (VRIII) is a high-risk medication that has a potential to cause significant patient harm if used in error. Complex preparation of VRIII in clinical areas and the need for frequent monitoring and adjustment increase the complexity of using VRIII. An emerging approach, called Resilient Healthcare, proposes understanding complexity of work by exploring how work is assumed to be done and compare it with everyday work. This study aimed to explore how VRIII is perceived to be used by healthcare practitioners, focusing on one aspect of Resilient Healthcare: understanding how work is assumed to be done, using a method called hierarchical task analysis (HTA). Design: A qualitative study using document analysis and focus groups. Setting: A vascular surgery unit in an acute National Health Service teaching hospital in the UK. Participants: Stakeholders/users in different professional roles involved in the process of using VRIII. Results: The HTA showed the complexity of using VRIII and highlighted more than 115 steps required to treat elevated blood glucose. The process of producing hospital-specific guidelines was iterative. Careful consideration was taken to coordinate the development and implementation of guidelines. Documents provided detailed clinical instructions related to the use of VRIII but practitioners selectively used them, often in deference to senior colleagues. Intentional adaptations, for example, proactively asking for a VRIII prescription occurred and were acknowledged as part of providing individualised patient care. Conclusion: Using VRIII to treat elevated blood glucose is a complex but necessary process mediated by a range of factors such as organisational influences. Adaptive strategies to mitigate errors were common and future research can build on insights from this study to develop a broader understanding of how VRIII is used and to understand how adaptations are made in relation to the use of VRIII.